Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2025
Promoting Human Immunodeficiency Virus Syndemic Care in Health Professions Education: Linking Workforce Demands to the Aspirations of a Rising GenerationPhilip Bolduc, Lydia Aoun Barakat, Elizabeth M Sherman, et al.The Lancet. Microbe|November 29, 2021
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.Journal of the International AIDS Society|November 28, 2019
HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, PeruWilliam L Trebelcock, Javier R Lama, Ann Duerr, et al.The Lancet. Microbe|May 11, 2022
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical studyMarta Massanella, Rachel A Bender Ignacio, Javier R Lama, et al.Open Forum Infectious Diseases|March 8, 2024
Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study-King County, Washington, May-October 2022Ellora N Karmarkar, Matthew R Golden, Roxanne P Kerani, et al.Plos One|July 8, 2024
Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activationEwelina Kosmider, Jackson Wallner, Ana Gervassi, et al.Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune ActivationEwelina Kosmider, Jackson Wallner, Ana Gervassi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 29, 2020
Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical StudyJavier R Lama, Rachel A Bender Ignacio, Ricardo Alfaro, et al.Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.Plos One|May 3, 2022
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisitionRachel A Bender Ignacio, Jessica Long, Aparajita Saha, et al.Pageof 5